Literature DB >> 18655829

Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.

Shaimaa M Badr-Eldin1, Seham A Elkheshen, Mahmoud M Ghorab.   

Abstract

The aim of this work was to investigate the inclusion complexation between tadalafil, a practically insoluble selective phosphodiesterase-5 inhibitor (PDE5), and two chemically modified beta-cyclodextrins: hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and heptakis-[2,6-di-O-methyl]-beta-cyclodextrin (DM-beta-CD), in comparison with the natural beta-cyclodextrin (beta-CD) in order to improve the solubility and the dissolution rate of the drug in an attempt to enhance its bioavailability. Inclusion complexation was investigated in both the solution and the solid state. The UV spectral shift method indicated guest-host complex formation between tadalafil and the three cyclodextrins (CDs). The phase solubility profiles with all the used CDs were classified as A(p)-type, indicating the formation of higher order complexes. The complexation efficiency values (CE), which reflect the solubilizing power of the CDs towards the drug, could be arranged in the following order: DM-beta-CD>HP-beta-CD>beta-CD. Solid binary systems of tadalafil with CDs were prepared by kneading and freeze-drying techniques at molar ratios of 1:1, 1:3 and 1:5 (drug to CD). Physical mixtures were prepared in the same molar ratios for comparison. Physicochemical characterization of the prepared systems at molar ratio of 1:5 was studied using differential scanning calorimetry (DSC), X-ray diffractometry (XRD), and Fourier-transform infrared spectroscopy (FTIR). The results showed the formation of true inclusion complexes between the drug and both HP-beta-CD and DM-beta-CD using the freeze-drying method at molar ratio of 1:5. In contrast, crystalline drug was detectable in all other products. The dissolution of tadalafil from all the prepared binary systems was carried out to determine the most appropriate CD type, molar ratio, and preparation technique to prepare inclusion complexes to be used in the development of tablet formulation for oral delivery of tadalafil. The dissolution enhancement was increased on increasing the CD proportion in all the prepared systems. Both the CD type and the preparation technique played an important role in the performance of the system. Irrespective of the preparation technique, the systems prepared using HP-beta-CD and DM-beta-CD yielded better performance than the corresponding ones prepared using beta-CD. In addition, the freeze-drying technique showed superior dissolution enhancement than other methods especially when combined with the beta-CD derivatives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655829     DOI: 10.1016/j.ejpb.2008.06.024

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  21 in total

1.  Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes.

Authors:  Jadel M Kratz; Marina R Teixeira; Karine Ferronato; Helder F Teixeira; Letícia S Koester; Cláudia M O Simões
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

Review 2.  Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges.

Authors:  Hong Wen; Huijeong Jung; Xuhong Li
Journal:  AAPS J       Date:  2015-08-15       Impact factor: 4.009

3.  Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.

Authors:  Wasfy M Obeidat; Al-Sayed A Sallam
Journal:  AAPS PharmSciTech       Date:  2014-01-09       Impact factor: 3.246

Review 4.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

5.  Remote loading of preencapsulated drugs into stealth liposomes.

Authors:  Surojit Sur; Anja C Fries; Kenneth W Kinzler; Shibin Zhou; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-28       Impact factor: 11.205

6.  Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.

Authors:  Mona Hassan Aburahma; Azza Ahmed Mahmoud
Journal:  AAPS PharmSciTech       Date:  2011-10-07       Impact factor: 3.246

7.  Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.

Authors:  Yassin El-Said Hamza; Mona Hassan Aburahma
Journal:  AAPS PharmSciTech       Date:  2009-11-18       Impact factor: 3.246

8.  Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.

Authors:  Gihan S Labib
Journal:  Drug Des Devel Ther       Date:  2015-09-07       Impact factor: 4.162

9.  Molecular Structure of Cefuroxime Axetil Complexes with α-, β-, γ-, and 2-Hydroxypropyl-β-Cyclodextrins: Molecular Simulations and Raman Spectroscopic and Imaging Studies.

Authors:  Barbara Gieroba; Grzegorz Kalisz; Anna Sroka-Bartnicka; Anita Płazińska; Wojciech Płaziński; Małgorzata Starek; Monika Dąbrowska
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

10.  Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.

Authors:  Ye Zhang; Qiang-Song Wang; Yuan-Lu Cui; Fan-Cui Meng; Ke-Ming Lin
Journal:  Int J Nanomedicine       Date:  2012-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.